What's happening
This bill requires hospital and emergency room physicians to notify a patient's prescriber when treating the patient for a controlled substance overdose.
Why it matters
Improves care coordination and patient safety. by ensuring that the doctor who originally prescribed a controlled substance learns when their patient has experienced an overdose, potentially allowing for better follow-up, intervention, and support.
Aims to reduce the risk of repeat overdoses or inappropriate prescribing. by closing the information gap between emergency/hospital physicians and the patient’s regular prescribers, who may not otherwise be aware of overdose incidents.
Strengthens the use of the state’s prescription monitoring program. by requiring hospital and emergency room practitioners to check the registry and notify prescribers, reinforcing oversight over controlled substance use and patient behavior.
Could impact prescribing practices and addiction treatment. by making prescribers more aware of their patients’ overdose events, possibly prompting reassessment of pain management strategies, referrals to addiction treatment, or adjustments to prescriptions.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Notify Doctors After Overdose
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to health
- Delivered to assembly
- Passed senateVote 63–0
- Ordered to third reading cal.864
- Committee discharged and committed to rules
- Referred to health
- Returned to senate
- Died in assembly
- Referred to health
- Delivered to assembly
- Passed senateVote 59–0
- Advanced to third reading
Show 3 earlier actions
- 2nd report cal.
- 1st report cal.386
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Notify Doctors of Overdose
In Assembly Committee · Health · Sponsor Michael Cusick
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2639
2017-2018 Regular Sessions
IN SENATE
January 13, 2017
Introduced by Sen. LANZA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to requiring hospital and emergency room physicians to notify a patient's prescriber that such patient is being treated for a controlled substance overdose
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraphs (i) and (j) of subdivision 1 of section 3371 of the public health law, as added by section 4 of part A of chapter 447 of the laws of 2012, are amended to read as follows:
(i) to a medical examiner or coroner who is an officer of or employed by a state or local government, pursuant to his or her official duties; [and]
(j) to an individual for the purpose of providing such individual with his or her own controlled substance history or, in appropriate circumstances, in the case of a patient who lacks capacity to make health care decisions, a person who has legal authority to make such decisions for the patient and who would have legal access to the patient's health care records, if requested from the department pursuant to subdivision six of section thirty-three hundred forty-three-a of this article or from a treating practitioner pursuant to subparagraph (iv) of paragraph (a) of subdivision two of this section; and
(k) to a practitioner to inform him or her that a patient is under treatment for a controlled substance overdose by hospital or emergency room practitioner for the purposes of subdivision two of this section.
§ 2. Paragraph (a) of subdivision 2 of section 3371 of the public health law, as amended by chapter 90 of the laws of 2014, is amended to read as follows:
(a) a practitioner, or a designee authorized by such practitioner pursuant to paragraph (b) of subdivision two of section thirty-three hundred forty-three-a or section thirty-three hundred sixty-one of this article, for the purposes of: (i) informing the practitioner that a patient may be under treatment with a controlled substance by another practitioner or that a patient is under treatment for a controlled
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00509-01-7
S. 2639 2
substance overdose; (ii) providing the practitioner with notifications of controlled substance activity as deemed relevant by the department, including but not limited to a notification made available on a monthly or other periodic basis through the registry of controlled substances activity pertaining to his or her patient; (iii) allowing the practitioner, through consultation of the prescription monitoring program registry, to review his or her patient's controlled substances history as required by section thirty-three hundred forty-three-a or section thirty-three hundred sixty-one of this article; and (iv) providing to his or her patient, or person authorized pursuant to paragraph (j) of subdivision one of this section, upon request, a copy of such patient's controlled substance history as is available to the practitioner through the prescription monitoring program registry; or
§ 3. Paragraph (a) of subdivision 2 of section 3371 of the public health law, as added by section 5 of part A of chapter 447 of the laws of 2012, is amended to read as follows:
(a) a practitioner, or a designee authorized by such practitioner pursuant to paragraph (b) of subdivision two of section thirty-three hundred forty-three-a of this article, for the purposes of: (i) informing the practitioner that a patient may be under treatment with a controlled substance by another practitioner or that a patient is under treatment for a controlled substance overdose; (ii) providing the practitioner with notifications of controlled substance activity as deemed relevant by the department, including but not limited to a notification made available on a monthly or other periodic basis through the registry of controlled substances activity pertaining to his or her patient; (iii) allowing the practitioner, through consultation of the prescription monitoring program registry, to review his or her patient's controlled substances history as required by section thirty-three hundred forty-three-a of this article; and (iv) providing to his or her patient, or person authorized pursuant to paragraph (j) of subdivision one of this section, upon request, a copy of such patient's controlled substance history as is available to the practitioner through the prescription monitoring program registry; or
§ 4. The opening paragraph of paragraph (a) of subdivision 2 of section 3343-a of the public health law, as added by section 2 of part A of chapter 447 of the laws of 2012, is amended to read as follows:
Every practitioner shall consult the prescription monitoring program registry prior to prescribing or dispensing any controlled substance listed on schedule II, III or IV of section thirty-three hundred six of this article, for the purpose of reviewing a patient's controlled substance history as set forth in such registry and every emergency room or hospital practitioner shall consult the prescription monitoring program registry when treating a patient for a controlled substance overdose and shall notify the patient's prescriber of such overdose; provided, however, that nothing in this section shall preclude an authorized practitioner, other than a veterinarian, from consulting the registry at his or her option prior to prescribing or dispensing any controlled substance. The duty to consult the registry shall not apply to:
§ 5. This act shall take effect immediately; provided, however, that the amendments to paragraph (a) of subdivision 2 of section 3371 of the public health law as amended by section two of this act shall be subject to the expiration and reversion of such subdivision pursuant to section 12 of chapter 90 of the laws of 2014, as amended, when upon such date the provisions of section three of this act shall take effect.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to requiring hospital and emergency room physicians to notify a patient's prescriber that such patient is being treated for a controlled substance overdose
Purpose or general idea of bill
Requires hospital and emergency room physicians to notify a patient's prescriber that such patient is being treated for a controlled substance overdose.
Summary of specific provisions
Sections 1 through 3 of the bill amends Public Health Law Section 3371 to extend provisions relating to the confidentiality of certain health records to the conveyance of information relating to the treatment of a patient for a controlled substance overdose.
Section 4 of the bill amends the opening paragraph of subdivision 2 of Public Health Law Section 3343-a by adding a requirement that every emergency room or hospital practitioner must consult the prescription monitoring program registry when treating a patient for a controlled substance overdose and also must. notify the patients prescriber of the controlled substance of the patients overdose.
Section 5 of the bill is the effective date.
Justification
In the past several years, New York State has recognized that the ramp- ant abuse and diversion. of opioids has necessitated the implementation of various anti-abuse policies. It is clear that these policies need to be approached comprehensively by government, law enforcement and health care providers.
Since 2013, New York State has required that prescribers are required to consult the Prescription Monitoring Program (PMP) Registry when prescribing Schedule II, Ill, and IV controlled substances. The informa- tion provided by this registry allows prescribers/practitioners to better evaluate their patients' treatment with controlled substances and determine whether there may be abuse of non-medical use.
This bill is a necessary and common sense extension of the purposes and requirements of (STOP and the prescription monitoring registry to insure that vital medical information is shared among health care practition- ers. The bill mandates that an emergency room or hospital practitioner take two steps in treating a patient with an opioid overdose: consult the prescription monitoring registry and notify the patient's prescriber of the patient's treatment for an overdose. Such notification provides the prescriber with information vital to the proper medical treatment of the patient. Without such notification cf the overdose, it is very possible that the prescriber/practitioner would not know that the patient had suffered an overdose of the opioid.
Prior legislative history
2017:S.2639- Passed Senate/A.1043-Referred to Health 2016:9.7946- Passed Senate/A.10229- Referred to Health
Fiscal implications
To be determined.
Effective date
This act shall take effect immediately; provided, however, that the amendments to paragraph (a) of subdivision 2 of section 3371 of the public health law as amended by section two of this act shall be subject to the expiration and reversion of such subdivision pursuant to section 12 of chapter 90 of the laws of 2014, as amended, when upon such date the provisions of section three of this act shall take effect.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.